APA (7th ed.) Citation

Frey, M. K., Kopparam, R. V., Ni Zhou, Z., Fields, J. C., Buskwofie, A., Carlson, A. D., . . . Chapman‐Davis, E. (2019). Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center. Cancer, 125(5), 690-697. https://doi.org/10.1002/cncr.31856

Chicago Style (17th ed.) Citation

Frey, Melissa K., Rohini V. Kopparam, Zhen Ni Zhou, Jessica C. Fields, Ama Buskwofie, Ann D. Carlson, Thomas Caputo, Kevin Holcomb, and Eloise Chapman‐Davis. "Prevalence of Nonfounder BRCA1/2 Mutations in Ashkenazi Jewish Patients Presenting for Genetic Testing at a Hereditary Breast and Ovarian Cancer Center." Cancer 125, no. 5 (2019): 690-697. https://doi.org/10.1002/cncr.31856.

MLA (9th ed.) Citation

Frey, Melissa K., et al. "Prevalence of Nonfounder BRCA1/2 Mutations in Ashkenazi Jewish Patients Presenting for Genetic Testing at a Hereditary Breast and Ovarian Cancer Center." Cancer, vol. 125, no. 5, 2019, pp. 690-697, https://doi.org/10.1002/cncr.31856.